AXL and neoplasm: A study by Flem-Karlsen et al. showed that sAxl concentrations were significantly higher in patients with advanced-stage melanoma, correlating with tumor Axl expression and poor therapeutic outcomes, particularly in those treated with immune checkpoint inhibitors [41].